PFW
AZN icon

Petros Family Wealth’s AstraZeneca AZN Stock Holding History

Petros Family Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,277
Closed -$252K – 135
2026
Q1 		$252K Sell
1,277
-4
-0.3% -$771 0.18% 109
2025
Q4 		$236K Buy
+1,281
New +$225K 0.16% 123

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Petros Family Wealth's AZN Position: Q2 2026 in Review

Petros Family Wealth sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,277 shares — an estimated $252K sold.

Petros Family Wealth first reported a position in AZN in Q4 2025 and held it in 2 quarters. The position peaked at $252K in Q1 2026. 487 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Petros Family Wealth reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Petros Family Wealth sold 1,277 AstraZeneca shares in Q2 2026, an estimated $252K.
  • Petros Family Wealth first reported a position in AstraZeneca in Q4 2025 and held it in 2 quarters.
  • Petros Family Wealth's AstraZeneca position peaked at $252K in Q1 2026.
  • 487 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Petros Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.